Local Institution

Saga, Saga-ken 849-8501

0 studies enrolling now · 4 studies all time

What they study most

Acute Coronary Syndrome, Atrial Fibrillation, Atrial Flutter, Hepatitis C, Hepatitis C Virus (HCV)

Studies at this site

• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3 — Completed
• Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy — Completed